Mackenzie Financial Corp Lexicon Pharmaceuticals, Inc. Transaction History

Mackenzie Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$1.05 - $3.67 $14,175 - $49,545	-13,500 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.3 $5,600 - $7,359	3,200 Added 31.07%	13,500 $27,000
Q1 2020 May 14, 2020	BUY	$1.8 - $4.28 $18,540 - $44,084	10,300 New	10,300 $20,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.